Catelani Michael 4
4 · Anixa Biosciences Inc · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Catelani Michael
President, COO & CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-03-10+500,000→ 500,000 totalExercise: $2.74Exp: 2032-03-10→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
- [F2]The options vest and become exercisable in thirty-six (36) equal monthly installments beginning March 31, 2022.